Cite
HARVARD Citation
Zaorsky, N. et al. (2014). Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?. Expert review of anticancer therapy. 14 (1), pp. 39-50. [Online].